Terminally misfolded or unassembled proteins in the early secretory pathway are degraded by a ubiquitin-and proteasomedependent process known as ER-associated degradation (ERAD). How substrates of this pathway are recognized within the ER and delivered to the cytoplasmic ubiquitin-conjugating machinery is unknown. We report here that OS-9 and XTP3-B/Erlectin are ER-resident glycoproteins that bind to ERAD substrates and, through the SEL1L adaptor, to the ER-membrane-embedded ubiquitin ligase Hrd1. Both proteins contain conserved mannose 6-phosphate receptor homology (MRH) domains, which are required for interaction with SEL1L, but not with substrate. OS-9 associates with the ER chaperone GRP94 which, together with Hrd1 and SEL1L, is required for the degradation of an ERAD substrate, mutant α 1 -antitrypsin. These data suggest that XTP3-B and OS-9 are components of distinct, partially redundant, quality control surveillance pathways that coordinate protein folding with membrane dislocation and ubiquitin conjugation in mammalian cells.
Folding of nascent polypeptide chains in the endoplasmic reticulum (ER) is monitored by a quality control process, which ensures that only correctly folded and assembled proteins are deployed 1 . Terminally misfolded or unassembled polypeptides are destroyed by a process known as ER-associated degradation (ERAD) [2] [3] [4] . Initially, ERAD substrates are situated either wholly or partially within the ER lumen and must first be dislocated across the ER membrane to be degraded. Covalent ubiquitin conjugation is required for tight coupling of substrate dislocation and targeting to the 26S proteasome for destruction [5] [6] [7] . Multiprotein complexes containing yeast [8] [9] [10] [11] and mammalian 12, 13 ER ubiquitin ligases have been identified and are thought to function as nexuses for the recognition, dislocation and ubiquitination aspects of ERAD.
The ability to distinguish native proteins from non-native states and folding intermediates in the ER lumen may rely on a 'glycan code' in which progressive trimming of terminal mannose residues on Man 9 GlcNAc 2 Asnlinked glycans by mannosidases serves as a molecular timer that specifies the folding history of the substrate protein 14 . An important clue to understanding how this code is deciphered by the quality-control apparatus was the discovery of EDEM (Htm1p in yeast), an α-mannosidase-like, ER-resident protein thought to function as a mannose-specific lectin that captures glycoproteins locked in futile cycles of folding and unfolding 15, 16 . EDEM and Htm1p are required for degradation of some, but not all misfolded glycoproteins.
Recently, a second lectin, Yos9p, was identified in Saccharomyces cerevisiae and may function as a crucial bridge linking mannose recognition to the ubiquitin conjugation system 9, [17] [18] [19] . Yos9p has an N-terminal signal sequence that delivers it to the ER and a C-terminal HDEL peptide that retains it in the ER lumen (Fig. 1a) . Deletion of Yos9p abrogates the degradation of the glycosylated but not the non-glycosylated forms of the lumenal ERAD substrate CPY* (refs 17, 18, 20) . Yos9p is able to discriminate between mutant CPY* and wild-type CPY, and seems to bind selectively to substrates that contain Man 8 GlcNAc 2 or Man 5 GlcNAc 2 glycans 19 . Yos9p is recruited into a protein complex containing the Hrd1p ubiquitin ligase and the lumenal chaperone Kar2p through association with Hrd3p, a lumenally exposed transmembrane tetratricopeptide repeat (TPR)-containing protein known to associate with Hrd1p 8, 9, 21 . Thus, Yos9p is a central component of a lumenal quality control surveillance system that connects substrate recognition to protein degradation.
The human genome contains two genes, XTP3-B (XTP3 transactivated protein, also known as Erlectin) 22 and OS-9 ( Fig. 1a) which share approximately 15% identity with Yos9p and approximately 23% identity with each other. Despite low overall homology among the three proteins, the presence of predicted N-terminal signal sequences, MRH domains and N-linked glycosylation sites suggests that XTP3-B and/or OS-9 may serve a function similar to that of Yos9p. XTP3-B was identified on the basis of its ability to interact with kremen 2 (Krm2), a plasma membrane co-receptor for Dickkopf (Dkk) in the Wnt/β-catenin signalling pathway 22 . XTP3-B has two MRH domains and, despite lacking a C-terminal KDEL sequence, is localized in the ER lumen 22 . Binding to Krm2 in vitro requires the C-terminal MRH domain and is abolished by Krm2 de-glycosylation, consistent with the conclusion that XTP3-B is a lectin.
OS-9 was originally identified in a screen for genes that are upregulated in osteosarcoma 23 and myeloid leukemia 24 . Fragments of OS-9 have also been identified independently in a number of yeast two-hybrid screens using cytoplasmic proteins as bait [25] [26] [27] . The interaction of OS-9 with proteins or domains located within the cytoplasm is surprising, as all three alternatively spliced isoforms are predicted to contain a canonical N-terminal signal sequence, an MRH domain and an N-linked glycan 24 ( Fig. 1a) . Here we show that OS-9 and XTP3-B are both ER-resident lectins that bind to ERAD substrates and to the membrane-embedded Hrd1-SEL1L ubiquitin ligase complex. Our data suggest that these lectins form an ERAD nexus that coordinates substrate recognition in the ER lumen with ubiquitin conjugation in the cytoplasm.
RESULTS

OS-9 and XTP3-B are ER-resident proteins
Endogenous XTP3-B and OS-9 in HeLa cells exhibited a prominent perinuclear reticular pattern of expression showing extensive overlap with immunofluorescence from an anti-KDEL antibody, similar to the pattern exhibited by Hrd1 (Fig. 1b) . Endogenous OS-9 in HEK293 cells migrated as two predominant electrophoretic species corresponding to OS-9.1 and OS-9.2 (Fig. 1c) . We were unable to detect OS-9.3, consistent with previous findings indicating that OS-9.1 and OS-9.2 mRNA is far more abundant 24 . Digestion with endoglycosidase H (EndoH) increased the mobilities of bands corresponding to OS-9.1 and OS-9.2, indicating that they may be ER-resident glycoproteins. OS-9.1 and OS-9.2 bound to concanavalin A (ConA), a lectin that selectively binds to high-mannose N-linked oligosaccharides, and were specifically eluted by methyl α-D-mannopyranoside. Together with the finding that the 34 N-terminal amino acids from OS-9 can functionally replace the signal sequence of an unrelated type I membrane protein (TCRα; Fig. 1d ), we conclude that isoforms 1 and 2 of endogenous OS-9, like XTP3-B, are bona fide ER-resident glycoproteins, consistent with a potential role in quality control surveillance in the ER lumen. OS-9 and XTP3-B interact with the Hrd1-SEL1L ubiquitin ligase SEL1L is a component of an ER multiprotein complex implicated in the process of recognition and/or dislocation of misfolded proteins 12, 28 . Like its yeast orthologue, Hrd3p, mammalian SEL1L is a type I transmembrane glycoprotein with the bulk of the protein (composed of eleven copies of the short tetratricopeptide-like 'Sel1' repeats 29 exposed to the ER lumen (Fig. 2a) . Previous studies have demonstrated that SEL1L interacts with the transmembrane ERAD components Hrd1, Derlin1 and Derlin2 as well as the cytoplasmic protein VCP/p97 (ref. 12). Fulllength S-tagged SEL1L (SEL1L WT ) co-precipitated with endogenous XTP3-B as well as the two OS-9 isoforms and Hrd1, suggesting that a multiprotein complex containing orthologues of Hrd1p-Hrd3p-Yos9p is conserved in mammalian cells (Fig. 2b) . Deletion of the C-terminal portion of SEL1L containing seven Sel1 repeats (SEL1L ) abolished all of these interactions, indicating that an intact lumenal domain is required for complex formation. Deletion of the C-terminal transmembrane domain (SEL1L ) decreased, but did not abolish, capture of Hrd1, OS-9 and XTP3-B (Fig. 2b) , similar to findings observed for Hrd3p interactions with Hrd1p and Yos9p 21 . This reduced association is probably due to secretion of SEL1L 1-737 as the mutant protein could be readily detected in the media (data not shown). Wild-type levels of interaction were restored when a KDEL retrieval signal was appended to the SEL1L 1-737 construct. Thus, the transmembrane domain of SEL1L is required for its retention in the ER, but not for its interaction with Hrd1, XTP3-B or OS-9. The identities of the two OS-9 isoforms pulled down by SEL1L were confirmed in transfected cells expressing S-tagged SEL1L with isoform-specific short-hairpin RNAs (shRNAs; Fig. 2c) . Finally, the sensitivity of both SEL1L-bound OS-9 isoforms to EndoH digestion (Fig. 2d ) supports the conclusion that these protein complexes are present within the ER lumen.
OS-9 and SEL1L are required for degradation of some ERAD substrates Both XTP3-B and OS-9 were co-immunoprecipitated with the null Hong Kong variant of α 1 -antitrypsin (NHK), a well-characterized ERAD substrate 16, 30, 31, 50 (Fig. 3a) . XTP3-B also bound to RI 332 (a mutant of ribophorin I and, like NHK, a lumenal ERAD substrate) 32 but not to the T-cell receptor α-subunit (TCRα; an unstable type I transmembrane protein) 33, 34 (Fig. 3b) . Knockdown of endogenous SEL1L or Hrd1 stabilized NHK, establishing that this ubiquitin ligase complex is essential for NHK degradation ( Fig. 3c; Supplementary Information, Fig. S3 ). Although knockdown of XTP3-B had no measurable effect on the kinetics or extent of NHK degradation, depletion of OS-9 was found to cause significant impairment of NHK clearance ( Fig. 3c ; Supplementary Information, Figure S3 ).
Knockdown of both XTP3-B and OS-9 did not enhance the effect observed with OS-9 shRNA alone, suggesting that XTP3-B does not functionally compensate for the absence of OS-9 (data not shown). By contrast, no appreciable stabilization of TCRα or RI 332 was observed following depletion of OS-9 or XTP3-B (Fig. 3d) . Thus, the MRH-domaincontaining proteins XTP3-B and OS-9 interact with and are functionally required for distinct sets of ERAD substrates.
SEL1L links XTP3-B and OS-9 to Hrd1
We used affinity capture combined with shRNA-knockdown of various components to define the organization of OS-9, SEL1L and Hrd1 into functional complexes. Although S-tagged XTP3-B and OS-9 are both able to bind to NHK, much greater levels of substrate bound at steady state to the former compared with the latter (Fig. 4a, CTRL) . We propose that this difference in the amount of NHK bound to the two lectins reflects more efficient transfer of the substrate to the downstream degradation machinery from OS-9, which is required for NHK degradation, than from XTP3-B, which is dispensable. This is supported by the observation that SEL1L-knockdown caused a marked increase in the total amount of NHK, as well as the amount of NHK bound to OS-9 ( Fig. 4a, SEL1L ). Consistently, S-tagged SEL1L bound robustly to endogenous XTP3-B and OS-9 as well as to Hrd1; none of these interactions was affected by knockdown of XTP3-B, OS-9 or Hrd1 (Fig. 4b) . By contrast, SEL1L-depletion abrogated binding of S-tagged Hrd1 to OS-9 ( Fig. 4c ) and S-tagged XTP3-B to Hrd1 (Fig. 4d ) without affecting the other Hrd1 and XTP3-B interactions. These data indicate that SEL1L mediates the interaction between the ERAD ubiquitin ligase Hrd1 and the two lectins, OS-9 and XTP3-B, and places them functionally upstream of the Derlin-VCP/p97 dislocation complex.
OS-9 and XTP3-B interact with ER chaperones
To characterize the protein complexes associated with mammalian Yos9p orthologues, detergent-soluble proteins associated with affinity-purified S-tagged XTP3-B and OS-9 were identified by 'shotgun' tandem LC-MS/MS (liquid chromatography-mass spectrometry/mass spectrometry) analysis (Table 1) . S-tagged lectins were captured from whole cells and from a rough microsome fraction enriched in the ER ( Supplementary Information, Fig. S4 ). Both lectins bound strongly to SEL1L, confirming the interactions we observed from functional depletion and pulldowns, and to GRP78/BiP, the lumenal Hsp70 class chaperone. The most prominent interaction for OS-9 was with GRP94, the ER-resident Hsp90 paralogue. We used immunoblot analysis to confirm that GRP94 interacts with ER quality-control components. S-tagged OS-9, but not EDEM or XTP3-B bound robustly to endogenous GRP94, confirming the interaction detected by MS (Fig. 5a) . Moreover, endogenous OS-9 (both isoforms) was clearly detected in immunoprecipitates of endogenous GRP94, confirming that the lectin-chaperone interaction is not an artefact of overexpression of S-tagged protein (Fig. 5b) . Although both GRP94 and SEL1L bind to OS-9, neither protein precipitated the other, indicating that they must form distinct complexes with OS-9. The interaction between S-tagged OS-9 and GRP94 was not disrupted by knockdown of SEL1L, Hrd1 or XTP3-B (Fig. 5c) , further supporting our conclusion that the interaction between GRP94 does not depend on the other components of the ERAD complex. In fact, the amount of BiP and GRP94 captured with OS-9 was elevated substantially when SEL1L or Hrd1 levels were reduced. Together, these data suggest that OS-9 partitions between a Hrd1-SEL1L complex and one containing substrate (Fig. 4a) and GRP94. Finally, knockdown of GRP94 stabilized NHK (Fig. 5d) , indicating that this ER chaperone is required for degradation of at least one well-established ERAD substrate.
Role of N-glycans in XTP3-B and OS-9 function
The presence of MRH domains in XTP3-B and OS-9 suggests that binding to N-glycans may contribute to their ability to recognize other components of the lumenal quality-control surveillance apparatus or, as has been suggested for Yos9p, substrates 17, 19 . We found that the interaction of XTP3-B with SEL1L and Hrd1 was markedly impaired by disrupting the putative sugar-binding pockets in both the first (R207A) and second (R428A) MRH domains, as well as a combination of the two (R207A/R428A; Fig. 6a ). SEL1L binding was completely abolished by deleting the 79 C-terminal amino acids containing one of the two MRH domains, as assessed by immunoblot analysis (Fig. 6a) or MS (data not shown). Binding to the ubiquitin ligase complex was decreased by G379S, a mutation previously reported to interfere with the interaction between XTP3-B and Krm2 (ref. 22) but not by eliminating the sole N-linked glycan (N195Q) of XTP3-B. As with XTP3-B, MRH-domain mutants (R188A) of either OS-9.1 or OS-9.2 exhibited a reduced amount of co-precipitated SEL1L (Fig. 6b) . This reduced binding to SEL1L was accompanied by an increase in captured GRP94, as observed for knockdown of SEL1L or Hrd1 (Fig. 5c ). These findings raise the possibility that the MRH domain of OS-9 is required for binding to SEL1L; the binding may be either direct (OS-9 binds to SEL1L) or indirect (OS-9 binds to SEL1L through a substrate).
To assess the role of sugar recognition in ERAD-substrate binding, we evaluated the ability of S-tagged XTP3-B-or OS-9 harbouring mutant MRH domains to bind to NHK (Fig. 6c) . The amount of NHK captured by these mutants, however, was similar to that bound to the wild-type proteins, suggesting that, as with Yos9p, the MRH domains of XTP3-B and OS-9 are dispensable for substrate binding. To determine whether substrate N-glycans are required, we co-expressed either XTP3-B or OS-9.1 with transthyretin (TTR), a non-glycosylated serum protein normally secreted by the liver. Mutations that destabilize the wild-type TTR homotetramer cause the protein to form amyloid deposits that underlie dominantly inherited familial TTR amyloidoses 35 . Wild-type TTR was not captured to an appreciable extent by XTP3-B or OS-9.1 (Fig. 6d, top) , consistent with the finding that this protein is efficiently folded in transfected cells 36 . By contrast, D18G and A25T, two amyloidogenic mutants shown previously to be ERAD substrates 36 , were detected in pulldowns of S-tagged XTP3-B but not S-tagged OS-9.1. This result was confirmed in the reverse experiment in which HAtagged D18G captured XTP3-B but not OS-9 (Fig. 6d, bottom) . The amount of TTR co-precipitated with XTP3-B correlated with the extent to which these TTR variants interact with BiP and inversely with the efficiency with which they are secreted 36 . Therefore, XTP3-B, but not OS-9, is capable of binding selectively to folding-defective lumenal proteins lacking N-glycans.
DISCUSSION
In this paper we describe two MRH-domain-containing, ER-resident proteins in mammalian cells that bind selectively to misfolded proteins and interact with the membrane-embedded ubiquitin ligase Hrd1 through SEL1L. Although these proteins share features with the Yos9p-Hrd1-Hrd3 system described in Saccharomyces cerevisiae, our data reveal several key differences between the yeast and mammalian systems. Chief among these is the unexpected role for GRP94, a protein that, despite its similarity to cytoplasmic Hsp90, has hitherto not been shown to have a direct role in ER quality control or ERAD. Our data implicate GRP94 in the role of regulating the assembly dynamics of protein complexes that present lumenal substrates to the ubiquitination and dislocation apparatus.
A model of how the lumenal surveillance mechanism may coordinate with the ubiquitination machinery in the mammalian ER is shown in Fig. 7 . Terminal mannoses of core N-glycans in proteins engaged in futile cycling in the ER lumen, or perhaps cycling between the ER and the cisGolgi, are progressively trimmed by mannosidases to a configuration compatible with binding to OS-9 or XTP3-B. How substrates partition between these two lectins is unclear at present, but our results suggests that the interaction with XTP3-B is unproductive for the substrates examined in this study. Given that mutation of the MRH domains does not affect substrate capture, and that XTP3-B is able to discriminate between native and misfolded, non-glycosylated TTR, we conclude that substrate interaction must involve additional, as yet undetermined structural features displayed by misfolded proteins. Our data suggest that instead of mediating substrate interaction, the MRH domains of OS-9 and XTP3-B may contribute to interaction with glycans on other ER-resident components of the ERAD/quality-control apparatus (for example, SEL1L). This is supported by the observation that the amount of SEL1L and Hrd1 co-precipitated with either lectin was markedly diminished by mutation of the MRH domains. One possibility suggested by the present work is that substrate recognition may be facilitated or mediated by molecular chaperones such as GRP94 and BiP, which associate with OS-9. GRP94 is the ER lumenal member of the Hsp90 class of chaperones. In contrast with other molecular chaperones, cytoplasmic Hsp90 seems to be required for folding only a limited range of substrates, most notably the steroid hormone receptors and other proteins involved in signal transduction 37 . Physiological substrates for GRP94 have not been identified, although a role in the assembly of toll-like receptors has been suggested 38, 39 . Despite its abundance in the cytoplasm, Hsp90 seems to function in different cellular pathways through its ability to interact with distinct sets of co-chaperones that regulate its interactions with substrates 40 . We speculate that, by analogy with the role of Hsp90 in assembling cytoplasmic receptor complexes, GRP94 may control the transfer of OS-9 (together with bound ligand) to the membrane ubiquitin-ligase-dislocation complex. Although we observed a strong GRP94 signal in OS-9 pulldowns, we failed to detect this chaperone coprecipitating with SEL1L, despite the presence of abundant amounts of OS-9. Thus, as with Hsp90, which dissociates from steroid hormone Model for coordinating lumenal surveillance with ubiquitination in mammalian ERAD. Nascent glycoproteins interact with the ER-resident chaperone calnexin (CNX) where they are either folded correctly and are released for subsequent trafficking to the Golgi apparatus (1) or in the case of misfolded proteins, re-enter the CNX cycle in an attempt to facilitate their maturation. If folding remains unproductive, the substrate becomes the target for demannosylation by ER α-mannosidase I to a Man 8 GlcNac 2 form (2). The trimmed mannose structure is recognized by EDEM and displaced from the CNX cycle (3) . Further demannosylation to a Man 5 or Man 6 form occurs by the actions of either ER-resident mannosidases (α-mannosidase I or possibly EDEM3), or in the case of cycling between the ER and the Golgi apparatus, Golgi Mannosidase I (4; ref. 49) . By analogy with Yos9p, these lower mannose structures may be part of the signal recognized by XTP3-B and OS-9 (5). OS-9 scaffolds the ER chaperones GRP94 and BiP, which may also help to prevent aggregation or facilitate unfolding of the substrate. OS-9/XTP3-B complexes bound to substrate subsequently interact with the lumenal domain of SEL1L (potentially through their MRH domains) which may facilitate the release of substrate in the case of OS-9 (6). XTP3-B forms a stable ternary complex with SEL1L and Hrd1 (7). For OS-9, binding to SEL1L displaces GRP94 and the substrate is transferred to the Hrd1-SEL1L complex (8) . The final step is release of OS-9 and dislocation of the substrate by the dislocation apparatus and subsequent ubiquitination in the cytoplasm (9) . In an alternative pathway, misfolded, non-glycosylated proteins may also enter this pathway, perhaps through interactions with XTP3-B (10).
receptors when a hormone binds, GRP94 binding to OS-9 seems to be mutually exclusive with that of SEL1L. Further study will be needed to address the relative contribution of GRP94 to ERAD substrate recognition versus regulating the assembly and disassembly of the Hrd1-SEL1L-OS-9 ERAD complex. A notable difference between Yos9p and its mammalian counterparts is the absence of a KDEL or other potential ER retention sequences from the mammalian proteins. Without a canonical retrieval sequence, XTP3-B/ OS-9 retention may be conferred by association with known ER resident proteins, as suggested for EDEM1 and EDEM2 (ref. 14). Retention of OS-9 in the ER may be accomplished by virtue of its interaction with the ER membrane through SEL1L or indirectly, through binding to GRP94/BiP. The secretion of overexpressed forms of XTP3-B 22 and OS-9 (data not shown) suggests that the available pool of retained molecules is limited.
Hrd1 and SEL1L, like their yeast counterparts, are present in a 1:1 stoichiometric complex in the ER membrane 12, 41 . However, shotgun MS analyses of microsomal fractions from a variety of mouse tissues showed a significantly greater number of SEL1L scans (5-7 fold), compared with Hrd1 (ref. 42) , suggesting that not all SEL1L may be associated with Hrd1. We found that the interaction between Hrd1 and SEL1L was labile and sensitive to detergents ( Supplementary Information, Fig. S1 ). This differs from the interaction between the yeast orthologues Hrd1p-Hrd3p, where the stoichiometric complex is captured quite readily 41 . Although S-tagged Hrd1 co-precipitated with both SEL1L and OS-9 (Fig. 4a) , Stagged OS-9 efficiently captured SEL1L but not Hrd1 (Fig. 5a ). By contrast, the XTP3-B-Hrd1-SEL1L complex can be co-precipitated with similar stoichiometries irrespective of the capture reagent. This suggests that SEL1L may interact sequentially with OS-9 and Hrd1, perhaps because the Hrd1-SEL1L interaction is destabilized by the interaction between SEL1L and OS-9. Moreover, the dramatic enhancement of NHK association with OS-9 following SEL1L knockdown suggests that SEL1L binding to these lectins may facilitate the transfer of substrate to Hrd1. Our data showing that interactions between SEL1L and OS-9 and Hrd1 do not require the SEL1L transmembrane domain, is consistent with those observed for Yos9p and Hrd1p with Hrd3p 9, 21, 41 . Moreover, the Hrd3p truncation 41 as well as the original Sel1 from Caernorhabditis elegans 29 are both functional, despite the lack of a transmembrane domain. It is not unreasonable to envision that the Hrd1-SEL1L interaction, mediated through the lumenal domains of both proteins, may be modulated by the binding of lumenal proteins such as OS-9.
Although XTP3-B and OS-9 share the ability to bind to a broad range of glycosylated and non-glycosylated proteins, knockdown experiments reveal that neither lectin is essential for this process. Further studies are needed to clarify the details of this complex pathway; however, the data reported here contribute to our understanding of the mechanisms by which misfolded proteins are recognized and sorted for destruction in the mammalian ER.
METHODS
Plasmids and constructs.
The following constructs were provided: Hrd1 (V. Chau, Penn State University, State College, PA), SEL1L (I. Biunno, Institute for Biomedical Technologies, Milan, Italy), V5-His 6 -OS-9 (G. Semenza, Johns Hopkins University, School of Medicine, Baltimore, MD) and transthyretin (TTR: wild-type, D18G, A25T; J. Kelly, Scripps Research Institute, La Jolla, CA). XTP3-B, OS-9.2 and EDEM1 were cloned from full-length expressed sequence tags (ESTs, Open Biosystems). XTP3-B and EDEM1 were amended with a C-terminal S-tag (KETAAAKFERQHMDS) and cloned into pcDNA3.1 (-) . The N-terminal S-tags for SEL1L and OS-9.1 and 2 were constructed from the signal sequence from bovine preprolactin followed by the S-tag and in frame fusion without endogenous signal sequences. All point mutations were made by Quikchange mutagenesis (Stratagene). The degradation substrates α1-antitrypsin NHK variant, TTR, TCRα, and RI 332 were HA-tagged at the C-terminus and subcloned into pcDNA3.1(-).
Short-hairpin RNAs (shRNAs).
Target sequences for shRNA-mediated knockdown (Supplementary Information, Table S1 ) were identified from the literature or generated using the small interfering RNA (siRNA) Selection Program at the Whitehead Institute 43 online repository (RNAi Codex, http://katahdin. cshl.org:9331/rnai/repository/scripts/newmain.pl) or a web-based design tool (Ambion, http://www.ambion.com/techlib/misc/psilencer_converter.html), with each based on the rules of Tuschl (ref. 44 ). All shRNAs were cloned into the pSUPERSTAR expression vector 45 .
Cell culture and transfections. HEK293s and HeLa S3 cells were maintained in DMEM containing 10% fetal bovine serum (FBS). Cells were transfected using either Fugene-6 (Roche) or the calcium-phosphate co-precipitation technique. Stable, clonal cell lines were selected by resistance to neomycin (1 mg ml -1 ) and limiting dilution.
Immuno-/affinity-purification and immunoblotting. All cells were collected manually in PBS, and lysed in buffer 46 containing either 1% Triton X-100 or 1% CHAPS and supplemented with protease inhibitor cocktail (Roche). Lysates were spun twice, first at 1000g and the supernatant spun again at 20,000g. After pre-clearing, S-tagged proteins were affinity-purified from cell lysates using S-protein agarose (Novagen). Samples were washed three times in lysis buffer without detergent, resuspended in loading buffer containing 5 mM dithiothreitol (DTT) and treated with EndoH (NEB) where specified. Samples were run on uniform or gradient SDS-PAGE gels and transferred to PVDF membranes for immunoblotting. Metabolic labelling and pulse-chase assays. Confluent plates of transfected HEK293 cells were incubated in methionine/cysteine (Met/Cys)-free DMEM for 10 min. Cells were metabolically pulse-labelled by supplementing met/cysfree DMEM with 35 S-Met/Cys (NEN EXPRE 35 S 35 S: 50 μCi per 6 cm dish) for 15 min. Labelling was terminated by rinsing cells twice with ice-cold phosphate buffered saline (PBS) supplemented with 5 mM Met/Cys. Labelled cells were gently collected, pelleted at 3000g for 10 sec. and lysed according to the conditions described above. Incorporation of 35 S-Met/Cys was normalized using methods described previously 47 . HA-tagged proteins were immunopurified by anti-HA 12CA5-coupled Protein A Sepharose and separated by SDS-PAGE. Dried gels were exposed and quantified by phosphoimaging (Molecular Devices).
Mass spectrometry. Rough microsomes were prepared from HEK293s cells stably expressing S-tagged proteins according to the protocol in ref. 48 . Starting whole-cell and rough microsome fractions were then lysed in 1% Triton X-100 and affinity-purified by S-protein agarose. Bead-bound complexes were washed three times in lysis buffer 46 , followed by five washes in 50 mM ammonium bicarbonate, pH 8. Bound proteins were eluted by overnight treatment with Rapigest (Waters), followed by trypsin digestion (Promega) prior to injection into the mass spectrometer. Samples were analysed on a system consisting of a CTC-PAL autosampler (Leap Technologies), a capillary gradient HPLC pump (Agilent Model 1100) and a linear-ion-trap mass spectrometer (Model LTQ, ThermoFisher Scientific). Solvents used for the chromatography were 0.1% aqueous formic acid (Solvent A) and 0.1% formic acid in acetonitrile (Solvent B). The chromatographic separations were performed on a 0.32 mm × 15 cm C18 reversed-phase column (MicroTech Scientific) at a flow rate of 8 μl min -1 and a gradient of 100% Solvent A to 40% Solvent B over 104 minutes. Column eluent was electrosprayed directly into the source of the mass spectrometer. The mass spectrometer was operated in a datadependent MS/MS mode in which the instrument cycled between full MS scans (m/z 300-2000) and intervening MS/MS scans on the ten most intense ions occurring in the MS scan. The acquired MS/MS spectra were searched using the Mascot protein database search program (Matrix Science) against a full database of human protein sequences to which the set of S-tagged protein sequences and S-protein sequence were added. Table S1 . Short-haipin RNA target sequences.
shRNA TARGET SEQUENCE SOURCE
